
    
      30 male patients diagnosed with IHH and a control group of 20 healthy cases with similar age
      and BMI were included in the study. The levels of advanced oxidation protein products (AOPP),
      thiol, malondialdehyde (MDA), nitric oxide (NO) and 8-hydroxydeoxyguanosine (8-OHdG) and the
      levels of triglyceride (TG), total cholesterol (TC), high density lipoprotein (HDL-K), low
      density lipoprotein (LDL-K), Apolipoprotein A1 (ApoA1) and Apolipoprotein B100 (ApoB100) were
      measured before and after gonadotrophin therapy.
    
  